Health Invest Partners Ab Ironwood Pharmaceuticals Inc Transaction History

Health Invest Partners Ab

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 08, 2022	SELL	$11.05 - $12.72 $7.85 Million - $9.03 Million	-710,000 Closed	0 $0
Q1 2022 May 05, 2022	SELL	$10.61 - $12.88 $212,200 - $257,600	-20,000 Reduced 2.74%	710,000 $8.93 Million
Q4 2021 Jan 18, 2022	BUY	$10.86 - $13.95 $488,700 - $627,750	45,000 Added 6.57%	730,000 $8.51 Million
Q3 2021 Nov 08, 2021	SELL	$11.92 - $13.92 $9.95 Million - $11.6 Million	-835,000 Reduced 54.93%	685,000 $8.95 Million
Q2 2021 Aug 10, 2021	BUY	$10.16 - $13.11 $711,200 - $917,700	70,000 Added 4.83%	1,520,000 $19.6 Million
Q1 2021 Apr 30, 2021	BUY	$9.04 - $11.86 $5.56 Million - $7.29 Million	615,000 Added 73.65%	1,450,000 $16.2 Million
Q4 2020 Feb 05, 2021	BUY	$9.05 - $12.2 $7.56 Million - $10.2 Million	835,000 New	835,000 $9.51 Million

237

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $706M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Health Invest Partners Ab, based on Form 13F filings with the SEC.

Stay updated on Health Invest Partners Ab with notifications on news.